Help Please log in to determine if you are eligible to purchase PT Programs. COPY NUMBER VARIANT SOLID TUMOR - CNVST  Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Analyte/Procedure Challenges per Shipment Number of Shipments Copy number variant—solid tumor 1 Two shipments per year Additional Information/Minimum Requirements This program is designed for laboratories using next-generation sequencing for copy number analysis. Laboratories will be asked to identify copy number alterations in some of these genes: CDKN2A, CDKN2B, EGFR, ERBB2, FGFR3, MET, MYC, MYCN, TP53. Copy number alterations tested will include amplification, gain, copy neutral loss of heterozygosity, and deletion. Program Information One 20-µL gDNA (10ng/µL) specimen Shipping Schedule Shipment A: June 7 Shipment B: November 22 Guest Log in/Register Customers Who Bought This Item Also Bought NGS SOLID TUMOR VIEW DETAILS > TUMOR MUTATIONAL BURDEN VIEW DETAILS >